Skip to content

The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU

The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU: A Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04617119
Enrollment
38
Registered
2020-11-05
Start date
2020-11-01
Completion date
2021-04-06
Last updated
2020-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Severe Systemic Illness Respiratory Muscle Fatigue

Keywords

Respiratory muscle strength, Inspiratory muscle training, Respiratory physical therapy, Patient exercise training, Maximal inspiratory pressure

Brief summary

This study aims to evaluate the effectiveness of respiratory muscle training with COVID-19 patient, who has underlying health conditions, in order to delay or prevent them from admitting to ICU.

Interventions

DEVICEThreshold IMT device

10 breaths X 3 sets, two times a day for 2 weeks. starting intensity 10 % of pre-measured maximal inspiratory pressure.

OTHERConventional physical therapy

daily

Sponsors

DR. JASSIM ALGHAITH
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

COVID-19 patient will be blinded from the study aim. The outcomes assessor will be blinded from the study aim and patient allocation.

Intervention model description

A pilot study following a randomized controlled trial design.

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Non- intubated patient diagnosed with moderate to severe pneumonia (confirmed by chest x-ray and officially reported) as secondary to COVID-19 with one more symptom such as: 1. Respiratory rate at ≥ 20 breath.min-1. 2. Oxygen saturation (SatO2) ≤ 90% at rest on room air. 3. Arterial partial pressure of oxygen (PaO2) ≤ 80 mmHg at resting. 4. PaO2/FiO2 ratio or P/F (is the ratio between the arterial partial pressure of oxygen and the percentage of oxygen supplied) \< 300mmHg.

Exclusion criteria

1. Patient that has received upper abdominal or thoracic surgery recently (≤ 3 months). 2. Cancer patients. 3. Pregnant patients. 4. Patient mentally unstable. 5. Patient with unstable cardiovascular or neurological functions. 6. Patients refusing to participate in this clinical trial. 7. Patient less the 21 years old (According to Kuwaiti Law). 8. Patients who have a language barrier who cannot understand Arabic or English.

Design outcomes

Primary

MeasureTime frameDescription
Changes in Respiratory muscle performanceBaseline, 1st week, 2nd week, one monthChanges in Respiratory muscle performance will be determined by using the Respiratory Pressure Meter device. Patient will perform full inspiration through this device for 1.5 seconds via the mouth (nose occluded). The reading of the negative peak pressure that is maintained for 1 second in the device is a maximal inspiration peak.

Secondary

MeasureTime frameDescription
Heart rateDaily from baseline to hospital discharge (2 weeks)measured by heart rate monitor before and after session
Oxygen saturationDaily from baseline to hospital discharge (2 weeks)Measured by pulse oximeter before and after session
Oxygen supplementationDaily from baseline to hospital discharge (2 weeks).Number of % of oxygen patient on it before and after session
Oxygen flow rateDaily from baseline to hospital discharge (2 weeks)measuring the number of time where the oxygen above or below 4L/min.
Blood pressureDaily from baseline to hospital discharge (2 weeks)Blood pressure measured by electronic BP machine before and after session
Pain levelDaily from baseline to hospital discharge (2 weeks)By using visual analogue scale. Possible score range from 0 (no pain) to 10 (worst possible pain) Before and after session.
Respiratory rateDaily from baseline to hospital discharge (2 weeks)Measured by Respiratory rate monitor. Before and after session
Threshold IMT deviceDaily from baseline to 1 month from admissionRecording number for breath and sets daily.
Dyspnoea levelDaily from baseline to hospital discharge (2 weeks)By using Borg scale (rating of perceived exertion scale), Possible score range from 0 (nothing) to 10 ( Maximal exertion). Before and after session.

Countries

Kuwait

Contacts

Primary ContactJassim M Alghaith, PhD.
Alghaith328@gmail.com(965)99558185
Backup ContactAbdulaziz Al-Husaini, MSc.
health_aura@hotmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026